Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 7;12(12):10347-10356.
doi: 10.1002/fsn3.4573. eCollection 2024 Dec.

Comparative Study on the Hypoglycemic Effects of Different Parts of Musa balbisiana

Affiliations

Comparative Study on the Hypoglycemic Effects of Different Parts of Musa balbisiana

Thi Ngoc Nhon Hoang et al. Food Sci Nutr. .

Erratum in

Abstract

Diabetes mellitus is a chronic metabolic disorder that can cause elevated blood glucose levels due to impaired insulin secretion or resistance. Different parts of Musa balbisiana have been used widely in traditional medicine to treat many disorders. The present study aims to evaluate the antidiabetic ability of the corm, pseudostem, inflorescence, fruit, peel, and seed of M. balbisiana via in vitro experiments by inhibiting α-amylase and α-glucosidase enzymes as well as in vivo models on diabetic alloxan-induced mice. The results show that all investigated parts have performed potential inhibition on two investigated digestive enzymes. Seed poses the highest capacity among surveyed parts on α-amylase (IC50:f μg/mL) and α-glucosidase (IC50: 21.63 μg/mL) as well as effectively lowers the blood glucose index (IG) in alloxan-induced mice. In addition, fruit, corm, and inflorescence are considered essential parts that have high hypoglycemic effects via in vivo experiments. These findings indicate that all M. balbisiana parts are possibly a potential source for hypoglycemic agents; further clinical studies are needed to evaluate the safety of human beings before applying them in functional food and pharmaceutical industries.

Keywords: Musa balbisiana; blood glucose index; hypoglycemia; α‐amylase; α‐glucosidase.

PubMed Disclaimer

Conflict of interest statement

All authors have read and agreed to the published version of the manuscript. The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
α‐amylase inhibition by extracts of different parts of M. balbisiana. In each bar, different letters in the bars represent a statistically significant difference at p < 0.05 according to ANOVA analysis.
FIGURE 2
FIGURE 2
α‐glucosidase inhibition by extracts of different parts of M. balbisiana. In each bar, different letters in the bars represent a statistically significant difference at p < 0.05 according to ANOVA analysis.
FIGURE 3
FIGURE 3
Photomicrograph of a section of the pancreas of normal control at 1000 μm (A), alloxan‐induced mice without treatment at 1000 μm (B), alloxan‐induced mice treated with seed sample 300 mg/kgBW (C), 400 mg/kgBW (D), and 500 mg/kgBW (E).

References

    1. Abdelkader, N. F. , Eitah H. E., Maklad Y. A., Gamaleldin A. A., Badawi M. A., and Kenawy S. A.. 2020. “New Combination Therapy of Gliclazide and Quercetin for Protection Against STZ‐Induced Diabetic Rats.” Life Sciences 247: 117458. 10.1016/j.lfs.2020.117458. - DOI - PubMed
    1. Ajiboye, B. O. , Oloyede H. O., and Salawu M. O.. 2018. “Antihyperglycemic and Antidyslipidemic Activity of Musa paradisiaca‐Based Diet in Alloxan‐Induced Diabetic Rats.” Food Science & Nutrition 6, no. 1: 137–145. 10.1002/fsn3.538. - DOI - PMC - PubMed
    1. Ajiboye, B. O. , Shonibare M. T., and Oyinloye B. E.. 2020. “Antidiabetic Activity of Watermelon (Citrullus lanatus) Juice in Alloxan‐Induced Diabetic Rats.” Journal of Diabetes & Metabolic Disorders 19: 343–352. 10.1007/s40200-020-00515-2. - DOI - PMC - PubMed
    1. Ansari, P. , Akther S., Hannan J. M. A., Seidel V., Nujat N. J., and Abdel‐Wahab Y. H.. 2022. “Pharmacologically Active Phytomolecules Isolated From Traditional Antidiabetic Plants and Their Therapeutic Role for the Management of Diabetes Mellitus.” Molecules 27, no. 13: 4278. 10.3390/molecules27134278. - DOI - PMC - PubMed
    1. Apostolidis, E. , Kwon Y. I., Shetty K., Apostolidis E., and Kwon Y. I.. 2006. “Potential of Cranberry‐Based Herbal Synergies for Diabetes and Hypertension Management.” Asia Pacific Journal of Clinical Nutrition 15, no. 3: 433–441. - PubMed

LinkOut - more resources